Study guide

12.3 Pain Management & Analgesics

ANCC Medical-Surgical Nursing Certification MEDSURG-BC

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts: Format, Scoring, Cost 1.2 Eligibility, Application & Scheduling 1.3 Blueprint Breakdown & Study Strategy 1.4 Test-Taking Strategies for ANCC Scenario Items

2 Assessment Skills

2.1 Health History Collection 2.2 Physical Assessment 2.3 Psychosocial Assessment 2.4 Cognitive & Neurological Screening

3 Diagnostics & Clinical Reasoning

3.1 Diagnostic & Laboratory Testing 3.2 Fluids & Electrolytes 3.3 Nursing Diagnosis Identification & Prioritization

4 Cardiovascular & Hematologic

4.1 Cardiovascular Assessment & Diagnostics 4.2 Cardiovascular Disorders & Management 4.3 Hematologic Disorders & Blood Products

5 Respiratory

5.1 Respiratory Assessment & Diagnostics 5.2 Respiratory Disorders & Management 5.3 Oxygen Therapy & Ventilation Support

6 Gastrointestinal & Renal

6.1 GI Assessment & Common Disorders 6.2 GI Management & Nutrition Support 6.3 Renal & Urinary Assessment & Disorders 6.4 Acute Kidney Injury & Renal Replacement Therapies

7 Neurologic & Musculoskeletal

7.1 Neurologic Assessment & Stroke 7.2 Neurologic Disorders & Management 7.3 Musculoskeletal Assessment & Disorders 7.4 Orthopedic Care, Immobilization & Mobility

8 Endocrine, Integumentary & Immune

8.1 Endocrine Assessment & Diabetes Management 8.2 Thyroid, Adrenal & Metabolic Disorders 8.3 Integumentary Disorders & Wound Care 8.4 Immune, Infectious & Multisystem Conditions

9 Care Planning & Education

9.1 Nursing Care Planning 9.2 Patient Teaching: Process & Evaluation 9.3 Education Topics & Self-Management 9.4 Health & Wellness Promotion

10 Perioperative Care

10.1 Preoperative & Intraoperative Care 10.2 Postoperative Complication Prevention 10.3 Postoperative Emergencies: Bleeding, Infection, Emboli

11 Patient Safety

11.1 Patient Safety: Falls, Restraints & Equipment 11.2 Infection Prevention & Isolation Precautions 11.3 Recognizing Deterioration & Escalation of Care

12 Pharmacology

12.1 Safe Medication Administration 12.2 Interactions & Adverse Effects 12.3 Pain Management & Analgesics 12.4 Polypharmacy & High-Alert Medications

13 Non-Pharmacologic & Comfort Care

13.1 Non-Pharmacologic Treatments & CAM 13.2 Comfort & End-of-Life Care

14 Therapeutic Communication

14.1 Therapeutic Communication 14.2 Cultural Competence & Family-Centered Care 14.3 Difficult Conversations & Counseling

15 Interprofessional Collaboration

15.1 Interdisciplinary Team Collaboration 15.2 Delegation & Supervision 15.3 Care Coordination, Consults & Transitions

16 Ethics & Evidence-Based Practice

16.1 Nursing Ethics & Patient Advocacy 16.2 Legal & Regulatory Foundations 16.3 Evidence-Based Practice & Research 16.4 Quality Improvement & Safety Culture

12.3 Pain Management & Analgesics

Key Takeaways Explain This Topic AI

Pain is whatever the patient says it is — assessment uses OLDCARTS plus a validated scale, and function matters more than the number alone

The WHO analgesic ladder steps from non-opioids to weak to strong opioids, with adjuvants at every rung

Acetaminophen is capped at 4 g/day from all sources (3 g/day for high-risk patients); combination opioid products hide acetaminophen

For PCA, only the patient presses the button — proxy dosing by family or staff has caused fatal respiratory depression

Assess sedation level before respiratory rate: a falling sedation score precedes opioid-induced respiratory depression, and naloxone's short half-life creates re-sedation risk

Last updated: August 2026

Pain Assessment

Pain is whatever the experiencing person says it is, existing whenever they say it does (McCaffery's definition). It is subjective and individualized — vital signs may be normal in severe chronic pain, so never use vitals alone to judge pain. Use a structured history:

OLDCARTS : Onset, Location, Duration, Character, Aggravating/Alleviating factors, Radiation, Timing, Severity.

Validated scales:

  • Numeric Rating Scale (0–10) — standard for verbal adults
  • Wong-Baker FACES — children ≥3 years and patients with language barriers
  • FLACC (Face, Legs, Activity, Cry, Consolability) — nonverbal children and impaired adults
  • PAINAD — advanced dementia
  • CPOT / BPS — critically ill, ventilated patients

Reassess after every intervention within the expected onset window (about 15–30 minutes IV, 60 minutes oral). Evaluate function — ability to cough, deep breathe, ambulate, and sleep — not just the number.

  • WHO Analgesic Ladder
  • Step 1 (mild, 1–3) : non-opioids — acetaminophen, NSAIDs ± adjuvants
  • Step 2 (moderate, 4–6) : add a weak opioid or low-dose strong opioid
  • Step 3 (severe, 7–10) : strong opioids — morphine, hydromorphone, fentanyl ± non-opioids and adjuvants

Dose by the clock for persistent pain (scheduled, not only PRN), use the oral route when possible, and individualize titration. Adjuvants belong at every step.

Multimodal Analgesia

Modern practice, especially in enhanced recovery after surgery (ERAS) pathways, uses multimodal analgesia : combining agents that act at different points of the pain pathway (acetaminophen + NSAID + regional block + gabapentinoid ± low-dose opioid) to improve relief and reduce total opioid exposure. Because the drugs work by different mechanisms, lower doses of each can be used, lowering the side-effect burden of any single class. Breakthrough pain — transient flares over a controlled baseline — is treated with short-acting rescue doses, and recurring breakthrough pain signals that the scheduled regimen needs re-evaluation rather than just more PRN doses.

  • Non-Opioid Analgesics
  • Acetaminophen

Maximum 4 g/day from all sources in healthy adults; limit to 3 g/day (or less) in older adults, hepatic impairment, malnutrition, or regular alcohol use . Combination products (e.g., hydrocodone/acetaminophen) count toward the total — hidden acetaminophen is a classic exam trap. Toxicity causes hepatic necrosis; the antidote is N-acetylcysteine .

NSAIDs

Ibuprofen, naproxen, ketorolac, celecoxib. Cautions:

GI — bleeding and ulceration; give with food; risk rises with age, steroids, anticoagulants

Renal — reduce renal perfusion; avoid in chronic kidney disease, dehydration, and with ACE inhibitors (the "triple whammy": NSAID + ACE-I/ARB + diuretic)

Cardiac — increased MI/stroke risk; avoid after CABG (boxed warning) and use cautiously in heart failure (sodium and fluid retention)

  • Ketorolac is limited to 5 days of use because of GI/renal risk
  • Opioids and Equianalgesia

Opioid classes: full mu agonists (morphine, hydromorphone, fentanyl, oxycodone), partial agonists (buprenorphine), and agonist-antagonists (nalbuphine — can precipitate withdrawal in opioid-dependent patients). Meperidine is avoided , especially in renal failure, because its metabolite normeperidine accumulates and causes seizures.

Equianalgesia : when rotating opioids, calculate the total 24-hour dose, convert using an equianalgesic table (oral morphine 30 mg ≈ IV morphine 10 mg ≈ oral hydromorphone 7.5 mg ≈ IV hydromorphone 1.5 mg), then reduce the new drug by 25–50% for incomplete cross-tolerance. Exact conversions are provider/pharmacy territory; the nurse's tested role is recognizing why the new dose is intentionally lower.

  • Opioid Safety
  • PCA Pumps

With patient-controlled analgesia (PCA) , only the patient presses the button. PCA by proxy — family members or nurses dosing a sleeping patient — bypasses the built-in safety that a sedated patient stops pressing, and has caused fatal respiratory depression. Verify pump programming with two clinicians at setup and every change.

Monitoring for Respiratory Depression

Assess sedation level before respiratory rate — excessive sedation precedes hypoventilation. The Pasero Opioid-Induced Sedation Scale (POSS) runs from S (sleeping, easy to arouse) through 4 (somnolent, minimal response to stimulation — stop the opioid, support respirations, give naloxone). A respiratory rate alone misleads: a patient breathing 12/min but difficult to arouse is in danger. Risk factors: opioid-naïve status, first 24 hours of therapy, sleep apnea, COPD, renal failure, concurrent sedatives.

Naloxone

Naloxone reverses opioid respiratory depression: dilute and titrate in small IV increments (e.g., 0.04–0.4 mg) to restore ventilation without full reversal and abrupt withdrawal pain. Its half-life (~30–90 minutes) is shorter than most opioids — re-sedation ( renarcotization ) is expected, so monitor for at least 2 hours after the last dose and anticipate repeat dosing or an infusion. Long-acting opioids and fentanyl patches make this worse; remember a removed patch keeps delivering drug from the skin depot for 12–24 hours.

Side-Effect Management

Constipation — the one opioid side effect to which patients never develop tolerance; start a stimulant laxative (senna) ± stool softener prophylactically , plus fluids, fiber, and ambulation

  • Nausea — usually transient; antiemetics early
  • Pruritus — often histamine-mediated, not a true allergy; antihistamines help
  • Urinary retention and sedation — monitor and dose-adjust
  • Adjuvant Analgesics

Gabapentinoids (gabapentin, pregabalin) — first-line for neuropathic pain (burning, shooting, diabetic neuropathy, postherpetic neuralgia); renal-dose and taper off

  • TCAs (amitriptyline, nortriptyline) — neuropathic pain; watch anticholinergic effects in older adults
  • Duloxetine — neuropathic and musculoskeletal pain
  • Corticosteroids — bone pain, nerve compression in palliative care
  • Safe Disposal and Diversion Awareness

Teach patients to dispose of unused opioids through take-back programs or authorized collectors ; the FDA flush list applies to high-risk drugs like fentanyl when take-back is unavailable. Never share opioids, store them securely, and never flush patches without folding them adhesive-to-adhesive. Nurses must also practice diversion prevention : waste partially used controlled substances with a witness, never carry others' access codes, and recognize that diversion endangers patients whose pain then goes untreated.